As many as one in three women treated for breast cancer undergo unnecessary procedures, but a new method for diagnosing it could do a better job distinguishing between benign and aggressive tumors.
Researchers at the University of Michigan are developing a pill that makes tumors light up when exposed to infrared light, and they have demonstrated that the concept works in mice.
Mammography is an imprecise tool. About a third of breast cancer patients treated with surgery or chemotherapy have tumors that are benign or so slow-growing that they would never have become life-threatening, according to a study out of Denmark last year. In other women, dense breast tissue hides the presence of lumps and results in deaths from treatable cancers. All that, and mammograms are notoriously uncomfortable.
“We overspend $4 billion per year on the diagnosis and treatment of cancers that women would never die from,” said Greg Thurber, U-M assistant professor of chemical engineering and biomedical engineering, who led the team. “If we go to molecular imaging, we can see which tumors need to be treated.”
The move could also catch cancers that would have gone undetected. Thurber’s team uses a dye that responds to infrared light to tag a molecule commonly found on tumor cells, in the blood vessels that feed tumors and in inflamed tissue. By providing specific information on the types of molecules on the surface of the tumor cells, physicians can better distinguish a malignant cancer from a benign tumor.
Compared to visible light, infrared light penetrates the body easily—it can get to all depths of the breast without an X-ray’s tiny risk of disrupting DNA and seeding a new tumor. Using a dye delivered orally rather than directly into a vein also improves the safety of screening, as a few patients in 10,000 can have severe reactions to intravenous dyes. These small risks turn out to be significant when tens of millions of women are screened every year in the U.S. alone.
But it’s not easy to design a pill that can carry the dye to the tumor.
“To get a molecule absorbed into the bloodstream, it needs to be small and greasy. But an imaging agent needs to be larger and water-soluble. So you need exact opposite properties,” Thurber said.
Fortunately, they weren’t the only people looking for a molecule that could get from the digestive system to a tumor. The pharmaceutical company Merck was working on a new treatment for cancer and related diseases. They got as far as phase II clinical trials demonstrating its safety, but unfortunately, it wasn’t effective.
“It’s actually based on a failed drug,” Thurber said. “It binds to the target, but it doesn’t do anything, which makes it perfect for imaging.”
The targeting molecule has already been shown to make it through the stomach unscathed, and the liver also gives it a pass, so it can travel through the bloodstream. The team attached a molecule that fluoresces when it is struck with infrared light to this drug. Then, they gave the drug to mice that had breast cancer, and they saw the tumors light up.
The research is described in a study in the journal Molecular Pharmaceutics, titled, “Oral administration and detection of a near-infrared molecular imaging agent in an orthotopic mouse model for breast cancer screening.”
The Latest on: Breast cancer diagnosis
via Google News
The Latest on: Breast cancer diagnosis
- WCM-Q raising awareness of breast cancer on November 12, 2018 at 9:53 pm
The Breast Cancer Awareness Fundraiser hosted education stations to tell people about the symptoms of breast cancer and to debunk some medical myths about the disease. Representatives of Qatar Cancer ... […]
- LexisNexis Risk Solutions Identifies Breast Cancer Treatment Facilities in the U.S. with the Highest Patient Populations on November 12, 2018 at 10:42 am
The analysis also determined that California, Florida and New York have the highest volume of patients diagnosed with breast cancer in 2018 – all with 600,000 or more cases. The number of patients rec... […]
- Breast Cancer Diagnosis Changes Surgeon's Patient Approach on November 11, 2018 at 9:18 pm
GREENVILLE, S.C. (AP) — A Greenville surgeon said she has new insight into what breast cancer patients endure after being diagnosed with the disease herself. "You don't really appreciate what patients ... […]
- Breast cancer survival rate in Qatar is 82.3%, says ministry on November 11, 2018 at 4:00 pm
a total of 248 cases of malignant breast cancer were diagnosed in the country in 2015. Of this 242 were women. The rate of breast cancer among men is relatively low with only six cases diagnosed in th... […]
- Woman settles case over breast cancer diagnosis on November 9, 2018 at 9:30 pm
Joan O'Sullivan (50), who has a mutation gene which means she is at higher risk of cancer, claimed she has suffered an alleged delay in the diagnosis and treatment of her cancer. She sued St James's H... […]
- Mum diagnosed with breast cancer on Valentine’s Day reveals signs all women should look for on November 9, 2018 at 6:20 am
A mum-of-two, who was diagnosed with breast cancer on Valentine’s Day is urging other women to get checked out, after undergoing gruelling treatment herself. Hayley Rock, 41, found a lump in her ... […]
- ABCD: After Breast Cancer Diagnosis on November 8, 2018 at 10:08 pm
Organization's mission statement: ABCD: After Breast Cancer Diagnosis nurtures hope and restores confidence in anyone affected by a breast cancer diagnosis. History of the organization: In 1992, Melod... […]
- Giuliana and Bill Rancic Talk Innovation and Quality of Life in Cancer Care on November 8, 2018 at 7:35 am
“I was diagnosed with breast cancer at 36, about seven years ago. And as one can imagine, it’s not anything I ever expected to hear, especially at 36, being healthy with no family history of ... […]
- A Lafayette mother receives breast cancer diagnosis on her birthday on November 6, 2018 at 6:41 am
LAFAYETTE, Ind. (WLFI) — About one in eight women will develop breast cancer at some point in her life according to experts at IU Health Arnett. A statics Lafayette teacher Gina Boyd had never heard u... […]
via Bing News